Journal Home > Volume 16 , Issue 1

The recurrence of head and neck squamous cell carcinoma (HNSCC) after surgical resection continues to pose a major challenge to cancer treatment. Advanced HNSCC exhibits a low response rate to immune checkpoint blockade (ICB), while photothermal therapy (PTT) can increase the infiltration of immune cells to make tumors more susceptible to cancer immunotherapy. In this regard, we designed and constructed a novel multifunctional nanocomposite comprised of oxidized bacterial cellulose (OBC), thrombin (TB), and gold nanocages (AuNCs) containing anti-programmed death 1 (PD-1) antibody (αPD-1@AuNCs), which allows the combination of therapies with remarkable postoperative antitumor immunity to control local tumor recurrence. The αPD-1@AuNCs displayed high light-to-heat conversion efficiency and induced pyroptosis under near infrared (NIR) irradiation, which activated a potent antitumor immune response. More importantly, the therapeutic system could induce tumor pyroptosis and enhance antitumor immune response by increasing T-cell infiltration and reducing the immune suppressive cells, when combined with local ICB therapy, which effectively avoided the tumor recurrence in a HNSCC postoperative mice model. Overall, the newly developed multifunctional nanocomposites could be a promising candidate for the treatment of postoperative HNSCC.

File
12274_2022_4811_MOESM1_ESM.pdf (1.1 MB)
Publication history
Copyright
Acknowledgements

Publication history

Received: 25 May 2022
Revised: 24 July 2022
Accepted: 25 July 2022
Published: 12 September 2022
Issue date: January 2023

Copyright

© Tsinghua University Press 2022

Acknowledgements

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Nos. 82072996 (Z. J. S.), 81874131 (Z. J. S.), 81702730 (L. L. B.), and 51973076 (G. Y.)), the Fundamental Research Funds for the Central Universities (No. 2042021kf0216) to Z. J. S., China Postdoctoral Science Foundation (Nos. 2018M630883 and 2019T120688) to L. L. B., and Wuhan Young Medical Talents Training Project to L. L. B.

Return